Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Anthracycline therapy is well-known for its adverse cardiac effects. Anthracycline-induced
cardiotoxicity (AIC) is associated with a poor prognosis; since classical heart failure
treatment can potentially reverse cardiac dysfunction at the early stage of cardiac toxicity,
early detection of AIC is crucial.
Transthoracic echocardiography is recommended for monitoring left ventricular function in
patients receiving these molecules. In routine practice, left ventricular systolic function
is mainly assessed by the left ventricular ejection fraction (LVEF), measured by
two-dimensional echocardiography imaging. However, LVEF depends on the operator's experience
and is not sensitive enough to detect subclinical myocardial dysfunction.
To overcome these limitations, two-dimensional speckle-tracking imaging has been proposed.
This technique allows for a study of global and regional myocardial deformation, especially
the longitudinal component, which appears to be the most sensitive one. Several studies have
already emphasized the role of global longitudinal strain (GLS) to detect slight alterations
in systolic function, especially in the setting of potentially cardiotoxic drugs and even
after low to moderate doses of anthracyclines. A recent expert consensus paper strongly
recommends GLS assessment for the detection of subclinical left ventricular dysfunction due
to anthracycline therapy.
Although there is growing evidence that GLS can predict subsequent alterations in LVEF, few
data exist on the optimal timing to perform echocardiography.
The investigators hypothesized that very early measurement of GLS in the time course of
anthracycline therapy could predict subsequent left ventricular systolic dysfunction.
The aim of this study was, therefore, to determine whether assessment of GLS after 150 mg/m²
of anthracyclines can predict AIC.